These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7510351)

  • 1. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood.
    Havel M; Grabenwöger F; Schneider J; Laufer G; Wollenek G; Owen A; Simon P; Teufelsbauer H; Wolner E
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):807-10. PubMed ID: 7510351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
    Lemmer JH; Stanford W; Bonney SL; Breen JF; Chomka EV; Eldredge WJ; Holt WW; Karp RB; Laub GW; Lipton MJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):543-51; discussion 551-3. PubMed ID: 7508070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of aprotinin on coronary artery bypass graft patency.
    Laub GW; Riebman JB; Chen C; Adkins MS; Anderson WA; Fernandez J; McGrath LB
    Chest; 1994 Nov; 106(5):1370-5. PubMed ID: 7525162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization.
    Kalangos A; Tayyareci G; Prêtre R; Di Dio P; Sezerman O
    Eur J Cardiothorac Surg; 1994; 8(12):651-6. PubMed ID: 7535064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy.
    Lass M; Welz A; Kochs M; Mayer G; Schwandt M; Hannekum A
    Eur J Cardiothorac Surg; 1995; 9(4):206-10. PubMed ID: 7541637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of aprotinin on bleeding during and graft patency after coronary artery bypass grafting].
    Minohara S; Asada K; Kondo K; Tatsumi T; Hasegawa S; Sawada Y; Morimoto T; Matsuyama N; Sasaki S
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jun; 45(6):821-4. PubMed ID: 9217377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical aprotinin on early postoperative bleeding and ICU stay after coronary artery bypass graft surgeries.
    Mehraien A; Ghafari A; Mohammadi SS
    Pak J Biol Sci; 2009 May; 12(10):813-6. PubMed ID: 19806814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens.
    Lemmer JH; Dilling EW; Morton JR; Rich JB; Robicsek F; Bricker DL; Hantler CB; Copeland JG; Ochsner JL; Daily PO; Whitten CW; Noon GP; Maddi R
    Ann Thorac Surg; 1996 Dec; 62(6):1659-67; discussion 1667-8. PubMed ID: 8957369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study.
    Samama CM; Langeron O; Rosencher N; Capdevila X; Rouche P; Pegoix M; Bernière J; Coriat P
    Anesth Analg; 2002 Aug; 95(2):287-93, table of contents. PubMed ID: 12145035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.